Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 4156 AL 4170

Intermittent Ventricular Pre-Excitation: Clinical Features and Electrophysiological Properties

Robles AG, Palamà Z, Santoro F, Rauber M, Antolič B, Gianfrancesco D, Bartolomucci F, Pellegrino P, Alfieri S, Borelli A, Scarà A, Luca GM, de Ruvo E, Calò L, Jan M, Pernat A, Romano S, Sciarra L.

J Cardiovasc Electrophysiol. 2025 Nov;36(11):2818-2826. doi: 10.1111/jce.70035. Epub 2025 Aug 7.

Deep-Brain Stimulation and Intensive Rehabilitation in a Patient with Parkinson Disease: A Case Report

Ferriero G, Magro VM, Ferrara PE, Ariani M, Coraci D, Codazza S, Maggi L, Ronconi G.

Am J Case Rep. 2025 Aug 8;26:e946308. doi: 10.12659/AJCR.946308.

Clinical Applications and Measurement Properties of the Digitized Archimedes Spiral Drawing Test: A Scoping Review

Wang S, Schwirtlich T, McLaughlin D, Beestrum M, Heinemann AW.

Mov Disord Clin Pract. 2025 Nov;12(11):1742-1755. doi: 10.1002/mdc3.70278. Epub 2025 Aug 7.

Approach to Cardiovascular Autonomic Dysfunction in Patients with Synucleinopathies

Lenka A, Beach P.

Mov Disord Clin Pract. 2025 Dec;12(12):2092-2105. doi: 10.1002/mdc3.70268. Epub 2025 Aug 7.

A Bioinformatic Analysis of BAG Protein Interactors and Pathways in Alzheimer's and Parkinson's Disease

Ramanan S, Johnson GV.

bioRxiv [Preprint]. 2025 Jul 23:2025.07.18.665492. doi: 10.1101/2025.07.18.665492.

mGluR4-Npdc1 complex mediates α-synuclein fibril-induced neurodegeneration

Perez-Canamas A, Chen M, Almandoz-Gil L, Khan N, Tang SJ, Ho A, Gunther EC, Strittmatter SM.

bioRxiv [Preprint]. 2025 Jul 21:2025.07.16.665194. doi: 10.1101/2025.07.16.665194.

Identification of Pesticides Associated with an Increased Risk of Parkinson's Disease using a Multi-Screen Approach

Arellano M, Barnhill LM, Kim AM, Hasan KMM, Li S, Paul KC, Peng C, Ritz B, Bronstein JM.

bioRxiv [Preprint]. 2025 Jul 26:2025.07.22.666186. doi: 10.1101/2025.07.22.666186.

Recent advances in cell membrane-based biomimetic delivery systems for Parkinson's disease: Perspectives and challenges

Kaur J, Thakran A, Naqvi S.

Asian J Pharm Sci. 2025 Aug;20(4):101060. doi: 10.1016/j.ajps.2025.101060. Epub 2025 Apr 21.

Neuroinflammation distinguishes HLA haplotypes in progressive supranuclear palsy

Forrest SL, Zaheer SS, Kim A, Tanaka H, Chasiotis H, Li J, Fox SH, Wang J, Tartaglia MC, Lang AE, Kovacs GG.

medRxiv [Preprint]. 2025 Jul 21:2025.07.21.25331869. doi: 10.1101/2025.07.21.25331869.

CDS-PD: A Novel Clinical Decision Support Platform for Parkinson's Disease

Gupta DK, Golnari P, Prantzalos K, Zurlo I, Iyer V, Lobb BM, Zweber C, Bulusu M, Clarke D, Boyd JT, Tatsuoka C, Hiller AL, Sahoo SS.

medRxiv [Preprint]. 2025 Jul 25:2025.07.24.25331875. doi: 10.1101/2025.07.24.25331875.

Probabilistic Mapping of Magnetic Resonance-Guided Focused Ultrasound (MRgFUS) Thalamotomy Targets in Essential Tremor and Tremor-Dominant Parkinson's Disease: Insights from a German Cohort

Krauss J, Upadhyay N, Purrer V, Borger V, Daamen M, Weiland H, Maurer A, Schmeel C, Radbruch A, Essler M, Wüllner U, Boecker H.

Mov Disord. 2025 Nov;40(11):2540-2542. doi: 10.1002/mds.70003. Epub 2025 Aug 8.

Ketogenic diet in the management of disease

Luong T, Svart M, Gormsen LC, Søndergaard E.

Curr Opin Clin Nutr Metab Care. 2025 Nov 1;28(6):477-482. doi: 10.1097/MCO.0000000000001158. Epub 2025 Aug 7.

Parkinsonism-hyperpyrexia syndrome due to gastroparesis treated with subcutaneous foslevodopa: a case report

Pandino C, Imbalzano G, Budicin S, Romagnolo A, Artusi CA, Zibetti M, Lopiano L, Rizzone MG.

J Neurol. 2025 Aug 8;272(9):564. doi: 10.1007/s00415-025-13313-8.

Acamprosate and risk of parkinsonism

d'Errico A, Strippoli E, Goldman SM, Blanc PD.

Parkinsonism Relat Disord. 2025 Oct;139:107986. doi: 10.1016/j.parkreldis.2025.107986. Epub 2025 Aug 7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias